Orexo AB, is a pharmaceutical company that develops and commercializes improved pharmaceuticals and digital therapies. The company addresses unmet needs within the growing space of mental illness and substance use disorders. In 2019 Orexo AB started a new business area in digital therapeutics with the mission to redefine treatment of addiction by offering clinically validated digital therapeutics to ensure more successful treatment for patients and cost-effective solutions for payers. In 2020 Orexo acquired the rights to a digital therapy for depression in the US and Orexo has a continued ambition to broaden the portfolio through acquisitions and in-licensing. Orexo’s first digital therapies are today commercialized by Orexo US where Orexo also commercializes its lead product ZUBSOLV® for the treatment of opioid use disorder. The first product where Orexo own the global right, modia®, is now launching in the US and next steps will be an expansion to new geographies.
Tasks
In the role as Business Development Manager of Digital Health you will be responsible for developing and executing business plans for Orexo's digital therapies outside the US, identifying and assessing new business opportunities in digital therapies, negotiating contracts with business partners, understanding the market conditions for digital therapies in different markets including regulatory and reimbursement pathways and establishing relationships with future potential partners for Orexo across the world. The work will be done in close collaboration and with the Team Head in Sweden and Orexo’s digital therapy team in the US. In this capacity you will help build, solidify and execute on the strategy outside the US as well as support the development of the digital team in Sweden. The position will be located in Stockholm, but occasional work from Orexo's head office in Uppsala should be expected.
Minimum Requirements
Bonus Requirements
Ad has been closed and it is no longer possible to apply.